MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Five Million Pregnancies Every Year Represents a Large Market for Prenatal Tests in the U.S. Says Frost & Sullivan - The desire to have healthy babies and the availability of fetal treatment options encourages parents-to-be to request prenatal tests - Frost.com
Five Million Pregnancies Every Year Represents a Large Market for Prenatal Tests in the U.S. Says Frost & Sullivan

 

NewswireToday - /newswire/ - Mountain View, CA, United States, 2011/11/18 - The desire to have healthy babies and the availability of fetal treatment options encourages parents-to-be to request prenatal tests - Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Prenatal testing for fetal defects will become critical as the risk of chromosomal abnormality increases with maternal age and women are commonly delaying motherhood. Prenatal microarray detects serious chromosomal abnormalities at a resolution that surpasses that of traditional karyotyping. While prenatal microarray still requires an invasive procedure such as an amniocentesis, pregnant women will have non-invasive prenatal diagnostics available to them in the near future.

New analysis from Frost & Sullivan’s (clinicaldiagnostics.frost.com) Strategic Analysis of the U.S. Prenatal Testing Market research finds that the market earned revenues of $1.28 billion in 2010 and estimates this to reach $1.59 billion in 2017. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: maternal serum screen, nuchal translucency (NT) ultrasound, karyotype, prenatal fluorescent in situ hybridization (FISH), and prenatal chromosomal array.

If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at britni.myers[.]frost.com, with your full name, company name, title, telephone number, company email address, company Website, city, state and country.

“Chromosomal abnormalities and other birth defects contribute to infant mortality in the United States and, therefore, early detection is important for healthy pregnancies and births,” said Frost & Sullivan Industry Analyst Winny Tan, Ph.D. “New prenatal screening options with improved detection rates for Down Syndrome have been effective in stratifying at-risk patients and lowering the number of invasive procedures for further diagnostic testing.”

Currently, the compliance rate for prenatal care is suboptimal. Individual attitudes that reflect religious beliefs or personal values help to explain why only 60 percent to 70 percent of pregnant women in the United States receive prenatal care. To increase compliance rates for prenatal care, test providers must focus on patient outreach, healthcare access and test reimbursement.

“For instance, the number of NT ultrasounds grew by 30 percent when the current procedural terminology (CPT) codes for the prenatal procedures were established,” said Tan. “Additionally, the American College of Obstetricians and Gynecologists' (ACOG) practice guidelines has influenced obstetricians and insurance companies to reimburse certain tests and procedures.”

Apart from patient-centric efforts, test providers must understand the demographic segmentation of their patients and expand their sales force and team of genetic counselors in pockets with high patient concentration.

“Prenatal diagnostic markets hold potential for sequencing technologies in the next decade, particularly in non-invasive prenatal diagnostics,” said Tan. “Understanding the current dynamics of the U.S. prenatal market will help determine the strongest applications for new technologies in this space.”

Strategic Analysis of the U.S. Prenatal Testing Market is part of the Clinical Diagnostics Growth Partnership Services program, which also includes research in the following markets: U.S. Preimplantation Genetic Diagnostics Market, U.S. Inherited Disease Molecular Diagnostics Market, EU Fetal and Neonatal Monitoring Equipment Market, and Advances in Fetal and Neonatal Diagnostics and Monitoring. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

Strategic Analysis of the U.S. Prenatal Testing Market / N940

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Five Million Pregnancies Every Year Represents a Large Market for Prenatal Tests in the U.S. Says Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Britni Myers - Frost.com 
210-477-8481 britni.myers[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Ventilator Challenge UK Consortium
MadgeTech Introduces The VTMS Wireless Vaccine Temperature Monitoring System
Florida Biodiesel, Inc. Has Developed A COVID-19 Disinfectant Generator
Bruker Introduces Updated B.I.QUANT-UR™ Module for Fully Validated Metabolite Quantification in Urine Using NMR
SCHOTT Extends SyriQ BioPure® Syringe Format to Enable Optimized Administration
Hand Hygiene Market Will Reach .98 Billion in the US and EU5 with High Adoption of Gamification Finds Frost & Sullivan
Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe Finds Frost & Sullivan
Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio™
Withings Launches ScanWatch - the First Hybrid Smartwatch to Combine Medical Grade Electrocardiogram and Sleep Apnea Detection
Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging
Inkwood Research Publishes Global 3D Cell Culture Market Forecast 2019-2027
Bruker’s PeakForce Tapping is Fastest Growing AFM Mode
Philips Commended by Frost & Sullivan for Advancing Access to Affordable, High-quality Care through Its Incisive CT Platform
ZOLL to Showcase Portfolio of Advanced Resuscitation Technologies for the Workplace At A+A Congress 2019
Bruker Launches Ultrafast FTIR Imaging Microscope LUMOS II

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)